{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:46:17Z","timestamp":1762098377776,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jcin.2009.10.008","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T05:42:14Z","timestamp":1261546934000},"page":"1208-1218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions"],"prefix":"10.1016","volume":"2","author":[{"given":"Martin B.","family":"Leon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Nikolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"O'Shaughnessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Overlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent T.","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John S.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Popma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2009.10.008_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.10.008_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.10.008_bib3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.10.008_bib4","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1161\/CIRCULATIONAHA.105.552190","article-title":"Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice","volume":"112","author":"Dawkins","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib5","article-title":"A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12-month outcomes from the ENDEAVOR IV trial","author":"Leon","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib6","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.10.008_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2009.10.008_bib9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.10.008_bib10","first-page":"455","article-title":"Late thrombosis after gamma-brachytherapy","volume":"58","author":"Maehara","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2009.10.008_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.CIR.0000028605.04359.FE","article-title":"Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS","volume":"106","author":"Waksman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jacc.2004.11.041","article-title":"Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis","volume":"45","author":"Ferrari","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2007.01.003","volume":"49","author":"Grines","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib17","first-page":"327","article-title":"Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force","volume":"69","author":"Hodgson","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2009.10.008_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2008.07.007","article-title":"Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents","volume":"52","author":"Awata","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib22","series-title":"Paper presented at: Transcatheter Cardiovascular Therapeutics 2008","article-title":"A prospective, randomized, controlled study using optical coherence tomography to evaluate strut coverage of sirolimus-, paclitaxel-, and zotarolimus-eluting coronary stents in long lesions requiring overlapping","author":"Guagliumi","year":"2008"},{"key":"10.1016\/j.jcin.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1536\/ihj.49.639","article-title":"Long-term coronary endothelial function after zotarolimus-eluting stent implantation","volume":"49","author":"Shin","year":"2008","journal-title":"Int Heart J"},{"key":"10.1016\/j.jcin.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2009.01.051","article-title":"A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction","volume":"53","author":"Kim","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib25","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/01.CIR.103.15.1967","article-title":"Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials","volume":"103","author":"Cutlip","year":"2001","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.jcin.2009.10.008_bib26","first-page":"124i","article-title":"Long term safety results from the Endeavor program: four-year follow-up","volume":"102","author":"Mauri","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib27","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib28","unstructured":"The Trees. Version 25.0. 2008. CMS MS-DRG Grouper. Eden Prairie, MN: Ingenix Corporation. Available at: www.ingenix.com. Accessed June 1, 2009."},{"year":"2008","series-title":"DRG Expert: A Comprehensive Guidebook to the DRG Classification System","key":"10.1016\/j.jcin.2009.10.008_bib29"},{"year":"2007","series-title":"DRG Plus! 2008: A Comprehensive Guide to Medicare Severity Diagnosis Related Groups","key":"10.1016\/j.jcin.2009.10.008_bib30"},{"year":"1995","series-title":"Per Case Prospective Payment for Episodes of Hospital Care","author":"Mitchel","key":"10.1016\/j.jcin.2009.10.008_bib31"},{"key":"10.1016\/j.jcin.2009.10.008_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10916-007-9120-x","article-title":"Outcomes of second revascularization procedures after stent implantation","volume":"32","author":"Konstance","year":"2008","journal-title":"J Med Syst"},{"key":"10.1016\/j.jcin.2009.10.008_bib33","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2008.01.042","article-title":"Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model","volume":"51","author":"Garg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0272989X9301300210","article-title":"Stability of time-tradeoff utilities in survivors of myocardial infarction","volume":"13","author":"Tsevat","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jcin.2009.10.008_bib35","first-page":"157","article-title":"First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: ENDEAVOR I trial","volume":"1","author":"Meredith","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2009.10.008_bib36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.008_bib37","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","article-title":"Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial","volume":"48","author":"Kandzari","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib38","doi-asserted-by":"crossref","first-page":"45M","DOI":"10.1016\/j.amjcard.2007.08.021","article-title":"Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients","volume":"100","author":"Gershlick","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib39","doi-asserted-by":"crossref","first-page":"77M","DOI":"10.1016\/j.amjcard.2007.08.026","article-title":"Real-world safety and efficacy of the endeavor zotarolimus-eluting stent: early data from the E-Five Registry","volume":"100","author":"Jain","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib40","doi-asserted-by":"crossref","first-page":"56M","DOI":"10.1016\/j.amjcard.2007.08.023","article-title":"Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study","volume":"100","author":"Meredith","year":"2007","journal-title":"Am J Cardiol"},{"issue":"Suppl E","key":"10.1016\/j.jcin.2009.10.008_bib41","first-page":"E27","article-title":"Randomized trial comparing the Endeavor zotarolimus-eluting stent and the Driver bare-metal stent in single de novo native coronary artery lesions: five-year clinical follow-up of ENDEAVOR II","volume":"5","author":"Wijns","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2009.10.008_bib42","series-title":"Presented at: EuroPCR","article-title":"Long term efficacy outcomes following treatment with zotarolimus-eluting stents: analysis of the pooled Endeavor program","author":"Kandzari","year":"2009"},{"key":"10.1016\/j.jcin.2009.10.008_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcin.2008.11.015","article-title":"Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer","volume":"2","author":"Byrne","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2009.10.008_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcin.2009.01.004","article-title":"Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?","volume":"2","author":"Finn","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2009.10.008_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/14656560902837998","article-title":"Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective","volume":"10","author":"Brugaletta","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jcin.2009.10.008_bib46","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0735-1097(02)02043-0","article-title":"Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries","volume":"40","author":"Hausleiter","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.008_bib47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/euhj.2001.2707","article-title":"Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry","volume":"23","author":"Uren","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2009.10.008_bib48","series-title":"Paper presented at: Transcatheter Therapeutics","article-title":"SORT-OUT III: A Prospective, Randomized Comparison of Zotarolimus-eluting and Sirolimus-eluting Stents in Patients with Coronary Artery Disease","author":"Lassen","year":"2008"},{"key":"10.1016\/j.jcin.2009.10.008_bib49","series-title":"Paper presented at: i2 Summit at ACC","article-title":"The Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions (ZEST) trial","author":"Park","year":"2009"},{"key":"10.1016\/j.jcin.2009.10.008_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCINTERVENTIONS.108.832048","article-title":"Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents","volume":"2","author":"Popma","year":"2009","journal-title":"Circ Cardiovasc Intervent"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809007237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809007237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:56:15Z","timestamp":1761846975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879809007237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1936879809007237"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.008","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}